$BIEL THREE RANDOMIZED, DOUBLE BLIND, PLACEBO CONT
Post# of 42179
Quote:
A randomized, controlled, double-blinded study that investigated the effectiveness of RecoveryRx in treating postoperative pain in 18 women who underwent breast augmentation surgery. These women presented with the following average baseline demographics: 31.6 years of age, weight of 134 lbs and height of 5.52 ft. The primary outcome was a difference in daily pain, measured on a 0-10 visual analog pain scale. The results indicate that the effect of active treatment with RecoveryRx provides a statistically significant treatment effect (reduction in postoperative pain), when compared to placebo (p<0.05). Link to publication: (https://lnkd.in/g5kKVaPs)
https://www.linkedin.com/feed/update/urn:li:a...946411009/